BRPI1002067A8 - Formulação leishmanicida e seu uso - Google Patents

Formulação leishmanicida e seu uso

Info

Publication number
BRPI1002067A8
BRPI1002067A8 BRPI1002067A BRPI1002067A BRPI1002067A8 BR PI1002067 A8 BRPI1002067 A8 BR PI1002067A8 BR PI1002067 A BRPI1002067 A BR PI1002067A BR PI1002067 A BRPI1002067 A BR PI1002067A BR PI1002067 A8 BRPI1002067 A8 BR PI1002067A8
Authority
BR
Brazil
Prior art keywords
leishmanicidal
formulation
solid
present
leishmaniasis
Prior art date
Application number
BRPI1002067A
Other languages
English (en)
Inventor
Antonio Ferraz Coelho Eduardo
César Bento Régis William
Garcia Valadares Diogo
Alberto Tavares Carlos
Original Assignee
Coop Dos Produtores De Cogumelos Da Regiao Metropolitana De Belohorizonte – Minasfungi Do Brasil
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coop Dos Produtores De Cogumelos Da Regiao Metropolitana De Belohorizonte – Minasfungi Do Brasil, Univ Minas Gerais filed Critical Coop Dos Produtores De Cogumelos Da Regiao Metropolitana De Belohorizonte – Minasfungi Do Brasil
Priority to BRPI1002067A priority Critical patent/BRPI1002067A8/pt
Priority to EP11779999.9A priority patent/EP2570131A4/en
Priority to PCT/BR2011/000147 priority patent/WO2011140623A1/pt
Priority to CN201180032139.9A priority patent/CN103491971A/zh
Priority to US13/697,534 priority patent/US20130142819A1/en
Publication of BRPI1002067A2 publication Critical patent/BRPI1002067A2/pt
Publication of BRPI1002067A8 publication Critical patent/BRPI1002067A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

FORMULAÇÃO LEISHMANICIDA E SEU USO. A presente invenção refere-se o desenvolvimento de formulações farmacêuticas obtidas a partir extrato de Agaricus blaze e suas frações purificadas para o tratamento da leishmaniose. Mais particularmente, a presente invenção descreve formulações preferencialmente de uso tópico e oral, sob as formas farmacêuticas sólidas, semi-sólidas e líquidas selecionadas do grupo compreendendo gel, creme, pomada, pastas, emulsões em geral, soluções, comprimidos e cápsulas.
BRPI1002067A 2010-05-11 2010-05-11 Formulação leishmanicida e seu uso BRPI1002067A8 (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI1002067A BRPI1002067A8 (pt) 2010-05-11 2010-05-11 Formulação leishmanicida e seu uso
EP11779999.9A EP2570131A4 (en) 2010-05-11 2011-05-11 FORMULATION AGAINST LEISHMANIOSIS AND USE THEREOF
PCT/BR2011/000147 WO2011140623A1 (pt) 2010-05-11 2011-05-11 Formulação leishmanicida e seu uso
CN201180032139.9A CN103491971A (zh) 2010-05-11 2011-05-11 杀利什曼原虫制剂及其应用
US13/697,534 US20130142819A1 (en) 2010-05-11 2011-05-11 Leishmanicidal formulation and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1002067A BRPI1002067A8 (pt) 2010-05-11 2010-05-11 Formulação leishmanicida e seu uso

Publications (2)

Publication Number Publication Date
BRPI1002067A2 BRPI1002067A2 (pt) 2015-02-18
BRPI1002067A8 true BRPI1002067A8 (pt) 2017-10-31

Family

ID=44922462

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1002067A BRPI1002067A8 (pt) 2010-05-11 2010-05-11 Formulação leishmanicida e seu uso

Country Status (5)

Country Link
US (1) US20130142819A1 (pt)
EP (1) EP2570131A4 (pt)
CN (1) CN103491971A (pt)
BR (1) BRPI1002067A8 (pt)
WO (1) WO2011140623A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103467613B (zh) * 2013-09-10 2015-12-09 上海瑞丰农业科技有限公司 一种姬松茸复合多糖的制备方法及其产品
US10905728B2 (en) * 2014-12-10 2021-02-02 Immunopharma As Agaricus blazei Murill extracts, methods for inhibiting legumain using the same, and methods for treating tumors using the same
CN107260754B (zh) * 2017-07-03 2020-02-14 天津农学院 一种畜禽养殖中使用姬松茸多糖抗艾美耳球虫的方法
IL299714A (en) * 2020-07-09 2023-03-01 Ceva Sante Animale Veterinary compositions for the prevention and/or treatment of leishmaniasis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01228480A (ja) * 1988-03-09 1989-09-12 Nippon Hai Potsukusu:Kk 食用担子菌菌糸体培養抽出物の製造方法
US5906825A (en) * 1997-10-20 1999-05-25 Magellan Companies, Inc. Polymers containing antimicrobial agents and methods for making and using same
JPH11263732A (ja) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd キノコ類抽出物含有皮膚外用剤
JPH11279204A (ja) * 1998-03-27 1999-10-12 Sumitomo Forestry Co Ltd 免疫抑制剤
JP2000032946A (ja) * 1998-07-22 2000-02-02 Pawafuru Kenko Shokuhin Kk 機能性食品
US6120772A (en) * 1998-10-08 2000-09-19 Hitoshi Ito Oral drugs for treating AIDS patients
US20020119164A1 (en) * 2000-08-18 2002-08-29 Shoji Uchiyama Use of agaricus blazei murill to prevent or treat skin and other disorders
CN1678335A (zh) * 2002-07-02 2005-10-05 协和工程株式会社 预防癌诱发或者癌转移的姬松茸提取物
NO20044581L (no) * 2004-01-12 2005-07-13 Geir Hetland Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier
EP1931360A2 (en) * 2005-08-01 2008-06-18 Abr, Llc Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens

Also Published As

Publication number Publication date
EP2570131A4 (en) 2013-12-18
CN103491971A (zh) 2014-01-01
US20130142819A1 (en) 2013-06-06
BRPI1002067A2 (pt) 2015-02-18
EP2570131A1 (en) 2013-03-20
WO2011140623A1 (pt) 2011-11-17

Similar Documents

Publication Publication Date Title
MX2016006896A (es) Microcapsulas de lipidos que comprenden preferiblemente una substancia activa lipofilica y composicion que las contiene, su metodo de preparacion y su uso en dermatolgia y cosmetica.
WO2012143576A3 (en) Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
FR2999429B1 (fr) Extrait de graines de passiflore et compositions cosmetiques, pharmaceutiques, dermatologiques ou nutraceutiques le comprenant
ES2478264T3 (es) Glicerosomas y uso de estos en preparaciones farmacéuticas y cosméticas para aplicación tópica
IL232158A (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
BR112015012565A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
PT2344198T (pt) Preparações farmacêuticas à base de lípidos para aplicação tópica
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
WO2012037328A3 (en) Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
BR112012012862A2 (pt) composição farmacêutica compreendendo oligopeptídeos
EP2643002A4 (en) PHARMACEUTICAL FORMULATIONS WITH CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
CO6920294A2 (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
BR112015012960A2 (pt) gel oral para o alívio da dor de dente
ECSP15000868A (es) Derivados de estra–1,3,5(10),16–tetraeno 3–sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos
CL2013000866A1 (es) Sales cristalinas oxalato y fosfato del conjugado naloxolpolietilenglicol; metodo de preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento del dolor.
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
BR112015027436A8 (pt) composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
AR087488A1 (es) Uso de composiciones para retrasar el inicio de la fase catagena del cabello
EP2570131A4 (en) FORMULATION AGAINST LEISHMANIOSIS AND USE THEREOF
BR112013026933A2 (pt) uso de uma combinação de pelo menos um carotenoide
WO2010054495A3 (en) Non-aqueous colloidal formulation
WO2012143857A8 (en) Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: IDENTIFIQUE O SIGNATARIO DA PETICAO INICIAL, E APRESENTE DOCUMENTO COMPROVANDO QUE ESTE POSSUI PODERES PARA REPRESENTAR O DEPOSITANTE.

B25C Requirement related to requested transfer of rights

Owner name: UNIVERSIDADE FEDERAL DE MINAS GERAIS (BR/MG)

Free format text: A FIM DE ATENDER A TRANSFERENCIA PARCIAL SOLICITADA ATRAVES DA PETICAO NO 014130000910, DE 13/05/2013, E NECESSARIO RECONHECER A FIRMA DOS REPRESENTANTES DA CEDENTE E DA CESSIONARIA, CONFORME ART. 9O DO DECRETO 6.932, DE 11/08/2009.

B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: COOPERATIVA DOS PRODUTORES DE COGUMELOS DA REGIAO

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2440 DE 10/10/2017 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL